SFM
AGIO icon

Sphera Funds Management’s Agios Pharmaceuticals AGIO Stock Holding History

Sphera Funds Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-116,000
Closed -$6.39M – 117
2021
Q2 		$6.39M Buy
+116,000
New +$6.49M 0.43% 64

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Sphera Funds Management's AGIO Position: Q1 2019 in Review

Sphera Funds Management sold out of Agios Pharmaceuticals (AGIO) in Q1 2019, closing a stake of 67,500 shares — an estimated $3.11M sold.

Sphera Funds Management first reported a position in AGIO in Q2 2014 and held it in 5 quarters. The position peaked at $3.25M in Q4 2015. 201 funds tracked by Wall St. Rank hold AGIO as of Q1 2019.

  • Sphera Funds Management reported no remaining Agios Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Sphera Funds Management sold 67,500 Agios Pharmaceuticals shares in Q1 2019, an estimated $3.11M.
  • Sphera Funds Management first reported a position in Agios Pharmaceuticals in Q2 2014 and held it in 5 quarters.
  • Sphera Funds Management's Agios Pharmaceuticals position peaked at $3.25M in Q4 2015.
  • 201 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2019.

Based on Sphera Funds Management's 13F filing for Q1 2019, filed 15 May 2019.